NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma

Clinical trial NCT04851834 · TERMINATED

Trial details

NCT number: NCT04851834
Sponsor: Xennials Therapeutics Australia Pty Ltd
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Platinum-Resistant Ovarian Cancer Platinum-Resistant Urothelial Carcinoma High-grade Glioma

Start date: 2021-08-25
Primary completion: 2022-11-08
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.